MedPath

First Affiliated Hospital of Wenzhou Medical University

People's Republic of China
Ownership
Private
Established
1956-01-01
Employees
-
Market Cap
-
Website
http://www.dyyy.xjtu.edu.cn/
Clinical Trials
Related News

The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19

Phase 2
Conditions
COVID-19 Thalidomide
Interventions
Drug: placebo
First Posted Date
2020-02-18
Last Posted Date
2020-02-21
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
40
Registration Number
NCT04273581

The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia

Phase 2
Conditions
COVID-19 Thalidomide
Interventions
Drug: placebo
First Posted Date
2020-02-18
Last Posted Date
2020-02-21
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
100
Registration Number
NCT04273529

A Metal Bare Stent With 125 Iodine （125I）Seeds for the Treatment of Malignant Central Airway Stenosis

Not Applicable
Conditions
Malignant Airway Obstruction
Interventions
Procedure: stent implantation
First Posted Date
2019-05-09
Last Posted Date
2019-05-09
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
200
Registration Number
NCT03944408
Locations
🇨🇳

The first affiliated hospital of wenzhou medical university, Wenzhou, Zhejiang, China

Anlotinib Hydrochloride as Second-line Therapy in Elderly Patients With EGFR Wild-type Lung Adenocarcinoma

Phase 2
Conditions
Non-Small-Cell Lung Cancer
Interventions
First Posted Date
2018-11-02
Last Posted Date
2018-11-02
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
38
Registration Number
NCT03728374

Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis.

Phase 4
Conditions
Acute Pancreatitis
Hypertriglyceridemia
Interventions
Device: plasmapheresis
First Posted Date
2018-04-18
Last Posted Date
2018-06-06
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
200
Registration Number
NCT03501680

Autologous CARTmeso/19 Against Pancreatic Cancer

Early Phase 1
Conditions
Pancreatic Cancer
Interventions
Biological: CARTmeso CART19
First Posted Date
2018-04-13
Last Posted Date
2018-04-13
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
10
Registration Number
NCT03497819
Locations
🇨🇳

First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma

Phase 1
Conditions
Hematopoietic/Lymphoid Cancer
Refractory Chronic Lymphocytic Leukemia
B-cell Adult Acute Lymphoblastic Leukemia
Adult Acute Lymphoblastic Leukemia in Remission
B-cell Chronic Lymphocytic Leukemia
Interventions
Biological: anti-CD19 CAR-T
First Posted Date
2017-04-12
Last Posted Date
2019-11-27
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
20
Registration Number
NCT03110640
Locations
🇨🇳

The First Affilicated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Comparison of His Bundle Pacing and Bi-Ventricular Pacing in Heart Failure With Atrial Fibrillation

Not Applicable
Conditions
Heart Failure
Atrial Fibrillation
Interventions
Device: CRT Device and Bi-ventricular pacing
Device: CRT Device and His-bundle Pacing
First Posted Date
2016-06-20
Last Posted Date
2016-06-20
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
50
Registration Number
NCT02805465
Locations
🇨🇳

First Affliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy